Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)

SHA:603139 Revenue

Shaanxi Kanghui Pharmaceutical had revenue of 199.65M CNY in the quarter ending September 30, 2026, with 83.82% growth. This brings the company's total for the last twelve months to 520.13M, up 1.34% year-over-year. In the year 2025, Shaanxi Kanghui Pharmaceutical had annual revenue of 471.29M, down -16.09%. That makes Shaanxi Kanghui Pharmaceutical the 24,633rd largest company in the world by revenue and 4,407th in China.

• Revenue (ttm): 520.13M
• Revenue Growth: +1.34%
• P/S Ratio: 5.47
• Revenue / Employee: 646.92K
• Employees: 804
• Market Cap: 2.85B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Manufacturing 270.20M 58.7%
• Pharmaceutical Distribution 173.71M 37.8%
• Others 16.18M 3.5%

Fiscal year ended Dec 31, 2025 See the full SHA:603139 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	471.29M	-90.35M	-16.09%
Dec 31, 2024	561.63M	-111.33M	-16.54%
Dec 31, 2023	672.96M	181.45M	36.92%
Dec 31, 2022	491.51M	48.75M	11.01%
Dec 31, 2021	442.76M	28.69M	6.93%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error